Can gabapentin be taken in the morning and pregabalin in the evening for a patient with neurogenic chronic cough?

Combining Gabapentin and Pregabalin for Neurogenic Chronic Cough

No, you should not take gabapentin in the morning and pregabalin in the evening for neurogenic chronic cough—choose one neuromodulator and use it consistently throughout the day according to its prescribed dosing schedule.

Why Not Combine These Medications?

Both gabapentin and pregabalin are structurally related neuromodulators that work through similar mechanisms (binding to the α2δ subunit of voltage-gated calcium channels). Combining them offers no proven additional benefit and significantly increases the risk of additive side effects including:

• Dizziness and somnolence
• Confusion and cognitive impairment
• Fatigue
• Nausea
• Blurred vision

The FDA labeling for pregabalin specifically notes that gabapentin coadministration does not alter the pharmacokinetics of either drug 1, but this doesn't mean combining them is clinically appropriate—it simply means they don't interfere with each other's absorption. There is no evidence supporting combination therapy for chronic cough.

Evidence-Based Approach to Neuromodulator Selection

First-Line Choice: Gabapentin

The 2016 CHEST guidelines specifically recommend gabapentin as the preferred neuromodulator for unexplained chronic cough 2. The recommendation is Grade 2C, with the following dosing protocol:

• Start: 300 mg once daily
• Titration: Add one additional 300 mg dose each day as tolerated
• Target: Up to 1,800 mg/day in two divided doses (maximum tolerable dose)
• Timing: Doses should not be separated by more than 12 hours 3

The guideline emphasizes discussing potential side effects and risk-benefit profile before initiation, with reassessment at 6 months before continuing 2.

Evidence supporting gabapentin:

• A 2012 randomized controlled trial demonstrated significant improvement in cough-specific quality of life (LCQ score difference of 1.80, p=0.004) with a number needed to treat of 3.58 4
• Side effects occurred in 31% of patients (primarily nausea and fatigue) versus 10% with placebo 2
• Particularly effective in patients with features of central reflex sensitization (laryngeal paresthesia, vocal fold motion asymmetry) 5

Alternative: Pregabalin

Pregabalin is an alternative neuromodulator, though not specifically mentioned in the CHEST guidelines. Recent evidence supports its use:

• A 2016 RCT showed combined pregabalin (300 mg daily) plus speech pathology therapy was superior to speech therapy alone, with mean LCQ improvement of 3.5 (95% CI 1.1-5.8) 6
• A 2023 pilot study demonstrated improved quality of life with pregabalin in resistant chronic cough 7
• French guidelines from 2023 list pregabalin alongside gabapentin as treatment options for unexplained/refractory chronic cough 8

Pregabalin dosing is typically 150-300 mg daily, though specific protocols for chronic cough are less well-established than for gabapentin.

Practical Algorithm for Neuromodulator Use

1. Start with gabapentin following the CHEST guideline protocol (300 mg daily, titrate to 1,800 mg/day in divided doses)

2. Monitor response at 4-8 weeks:

   • If effective: Continue at lowest effective dose
   • If ineffective or intolerable side effects: Consider switching to pregabalin (not adding it)

3. If switching to pregabalin:

   • Taper gabapentin over 1 week minimum 3
   • Start pregabalin at 150 mg daily, titrate to 300 mg as needed

4. Reassess at 6 months to determine if continued therapy is warranted 2

Common Pitfalls to Avoid

• Don't combine neuromodulators without clear evidence of benefit—this only multiplies side effect risk
• Don't use once-daily dosing for gabapentin—the FDA label specifies divided doses with maximum 12-hour intervals 3
• Don't skip the diagnostic workup—ensure the cough is truly unexplained/refractory before starting neuromodulators 2
• Don't forget speech pathology therapy—this is also a Grade 2C recommendation and may be synergistic with pharmacotherapy 2, 6

The Bottom Line

Select one neuromodulator (preferably gabapentin based on guideline recommendations) and use it at appropriate divided doses throughout the day. There is no rationale for splitting different neuromodulators by time of day, and doing so increases harm without proven benefit. If gabapentin fails or is not tolerated, switch completely to pregabalin rather than combining them.